相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events
Meir Preis et al.
BLOOD (2017)
Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study
P. Gueret et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis
C. Zhong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation
Cynthia A. Jackevicius et al.
HEART (2017)
Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker
James R. Corte et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release
K. -A. Steen Burrell et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Inorganic polyphosphate: a key modulator of inflammation
S. M. Hassanian et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Novel antiplatelet role for a protein disulfide isomerase-targeted peptide: evidence of covalent binding to the C-terminal CGHC redox motif
H. R. Sousa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
A new antithrombotic strategy: inhibition of the C-terminal active site of protein disulfide isomerase
L. Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review
Sung M. Cho et al.
NEUROCRITICAL CARE (2017)
Laboratory Assessment of Direct Oral Anticoagulants
Jonathan Douxfils et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Generation and characterization of aptamers targeting factor XIa
R. S. Woodruff et al.
THROMBOSIS RESEARCH (2017)
Macrocyclic factor XIa inhibitors
Cailan Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Macrocyclic inhibitors of Factor XIa: Discovery of alkyl-substituted macrocyclic amide linkers with improved potency
James R. Corte et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors
Isao Sakurada et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Idarucizumab for the Reversal of Dabigatran
Michael Gottlieb et al.
ANNALS OF EMERGENCY MEDICINE (2017)
Discovery and characterization of an antibody directed against exosite I of thrombin
T. P. Baglin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Inhibition of Protein Disulfide Isomerase in Thrombosis
Roelof H. Bekendam et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2016)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPACE (2016)
The discovery of dabigatran etexilate for the treatment of venous thrombosis
Martin Feuring et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Factor XIa inhibitors: A review of the patent literature
Rami A. Al-Horani et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
The Intrinsic Pathway of Coagulation as a Target for Antithrombotic Therapy
Allison P. Wheeler et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer
Thomas J. Povsic et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Trends in the Management and Outcomes of Acute Pulmonary Embolism Analysis From the RIETE Registry
David Jimenez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
A. Michael Lincoff et al.
LANCET (2016)
Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI
Cristina Puy et al.
PLOS ONE (2016)
Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile
Rami A. Al-Horani et al.
PLOS ONE (2016)
Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant
Erin E. Soule et al.
NUCLEIC ACID THERAPEUTICS (2016)
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
Xiaoxi Yao et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
P-Selectin Inhibition Therapeutically Promotes Thrombus Resolution and Prevents Vein Wall Fibrosis Better Than Enoxaparin and an Inhibitor to von Willebrand Factor
Jose A. Diaz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Modulation of the Coagulation Cascade Using Aptamers
Rebecca S. Woodruff et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Development of a novel class of potent and selective FIXa inhibitors
Ting Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives
Antonio Gomez-Outes et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Factor XI and contact activation as targets for antithrombotic therapy
D. Gailani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIa
Pancras C. Wong et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2015)
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
Harry R. Bueller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Laboratory Testing in the Era of Direct or Non-Vitamin K Antagonist Oral Anticoagulants: A Practical Guide to Measuring Their Activity and Avoiding Diagnostic Errors
Emmanuel J. Favaloro et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants
Rami A. Al-Horani et al.
THROMBOSIS RESEARCH (2015)
Fasxiator, a novel factor XIa inhibitor from snake venom, and its site-specific mutagenesis to improve potency and selectivity
W. Chen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012
Paul L. Hess et al.
AMERICAN HEART JOURNAL (2014)
Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis
Richard J. Travers et al.
BLOOD (2014)
Allosteric Inhibition of Human Factor Xla: Discovery of Monosulfated Benzofurans as a Class of Promising Inhibitors
Malaika D. Argade et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management
Gergana Galabova et al.
PLOS ONE (2014)
Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants
Rajesh A. Shenoi et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Identification and characterisation of novel inhibitors on extrinsic tenase complex from Bungarus fasciatus (banded krait) venom
Wan Chen et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Stroke in Dialysis and Chronic Kidney Disease
Albert Power
BLOOD PURIFICATION (2013)
Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences
Rajiv Chowdhury et al.
EUROPEAN HEART JOURNAL (2013)
Designing Allosteric Regulators of Thrombin. Exosite 2 Features Multiple Subsites That Can Be Targeted by Sulfated Small Molecules for Inducing Inhibition
Preetpal Singh Sidhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer
R. S. Woodruff et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement A randomised, controlled trial
Peter Verhamme et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model
Maurits L. van Montfoort et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Active immunotherapy for chronic diseases
Martin F. Bachmann et al.
VACCINE (2013)
The discovery of rivaroxaban: translating preclinical assessments into clinical practice
Dagmar Kubitza et al.
FRONTIERS IN PHARMACOLOGY (2013)
Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys
Husam S. Younis et al.
BLOOD (2012)
Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation
Stephanie A. Smith et al.
BLOOD (2012)
Prevention of VTE in Orthopedic Surgery Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Yngve Falck-Ytter et al.
CHEST (2012)
Prevention of VTE in Nonorthopedic Surgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Michael K. Gould et al.
CHEST (2012)
A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity
K. M. Bompiani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Inhibition of Factor XII-Mediated Activation of Factor XI Provides Protection Against Experimental Acute Ischemic Stroke in Mice
Philberta Y. Leung et al.
TRANSLATIONAL STROKE RESEARCH (2012)
Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2011)
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding
Alexey S. Revenko et al.
BLOOD (2011)
Aptamer-based modulation of blood coagulation
G. Mayer et al.
HAMOSTASEOLOGIE (2011)
Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial
P. Verhamme et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor
Pancras C. Wong et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
Edoxaban: pharmacological principles, preclinical and early-phase clinical testing
Ramon A. Partida et al.
FUTURE CARDIOLOGY (2011)
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
C. Frank Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo
Qiufang Cheng et al.
BLOOD (2010)
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk
Hong Zhang et al.
BLOOD (2010)
Tolerability and Pharmacokinetics of TB-402 in Healthy Male Volunteers
Peter Verhamme et al.
CLINICAL THERAPEUTICS (2010)
An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase
Sai K. Buddai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Nucleic acid aptamers as antithrombotic agents: Opportunities in extracellular therapeutics
Richard C. Becker et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
Erik I. Tucker et al.
BLOOD (2009)
Platelet inorganic polyphosphate decreases in patients with delta storage pool disease
L. Hernandez-Ruiz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa
Donald J. P. Pinto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology - A phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity
Christopher K. Dyke et al.
CIRCULATION (2006)
An overview of the structure and function of thrombin
Earl W. Davie et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
What is all that thrombin for?
KG Mann et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
RNA aptamers as reversible antagonists of coagulation factor IXa
CP Rusconi et al.
NATURE (2002)
分享论文
